- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01430208
A New Alternative to Traditional Hysteroscopy
September 7, 2011 updated by: Maurizio Guido, Catholic University of the Sacred Heart
New Mini-resectoscope as Alternative to Traditional Hysteroscopy in the Treatment of Uterine Lesions
Hysteroscopy is a procedure designed for the diagnosis and the treatment of intra-uterine diseases.
The development of smaller hysteroscopes allowed to change the approach to the intra-uterine lesions unifying the diagnostic and operative time.
Recently Gubbini et al. developed a mini-resectoscope feasible for "see&treat" hysteroscopy.
The objective of the study is to compare the new 16 Fr mini28 resectoscope by Gubbini with Traditional 22 Fr resectoscope and Bettocchi 15 Fr hysteroscope for the treatment of uterine cavitary lesions.
The investigators enrolled 401 women affected by endometrial polyps and/or G0 myomas, randomly allocated to receive the treatment with traditional resectoscope (127 women), with mini-resectoscope by Gubbini (142 women) and Bettocchi hysteroscope (132 women).
Operating time, distension media delivered, dismiss time and discomfort experienced were recorded.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
401
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Rome, Italy, 00168
- Catholic University of Sacred Heart
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- women between 18-75 years of age
- endometrial polyps and/or G0 myomas smaller than 3 cm of diameter
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: mini-resectoscope
|
hysteroscopy for myomas G0 and/or polyps
|
|
Active Comparator: tradiorional resectoscope
|
hysteroscopy for myomas G0 and/or polyps
|
|
Active Comparator: bettocchi resectoscope
|
hysteroscopy for myomas G0 and/or polyps
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
efficacy of the treatment with mini-resectoscope in comparison with the traditional hysteroscopy in the whole group of 401 patients
Time Frame: sixteen months
|
Operating time (min), distension media used (ml), dismiss time (hours), patients discomfort (VAS)
|
sixteen months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
efficacy of the treatment with mini-resectoscope in comparison with the traditional hysteroscopy in the treatment of intrauterine lesions larger than 1,5cm in diameter
Time Frame: sixteen months
|
Operating time(min), distension media used (ml), dismiss time (hours), patients discomfort (VAS)
|
sixteen months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2010
Primary Completion (Actual)
April 1, 2011
Study Completion (Actual)
June 1, 2011
Study Registration Dates
First Submitted
September 2, 2011
First Submitted That Met QC Criteria
September 7, 2011
First Posted (Estimate)
September 8, 2011
Study Record Updates
Last Update Posted (Estimate)
September 8, 2011
Last Update Submitted That Met QC Criteria
September 7, 2011
Last Verified
September 1, 2011
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- HUMREP-11-0778
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Polyps
-
Eisai Inc.PPD; Covance; Quest Pharmaceutical ServicesTerminated
-
Eisai Inc.Omnicare Clinical Research; MDS Pharma Services; Bio Analytical Research Corporation and other collaboratorsCompletedColonoscopy | Colon Polyps
-
Eisai Inc.PPD; MDS Pharma Services; Bio Analytical Research Corporation; Coghlan Group (Plasma...CompletedColonoscopy | Colon Polyps
-
Biotax Labs LTDRecruiting
-
Seoul National University HospitalCompletedColon PolypKorea, Republic of
-
Portuguese Oncology Institute, CoimbraCompleted
-
VA Greater Los Angeles Healthcare SystemTerminatedScreening of Colonic PolypsUnited States
-
Affiliated Hospital to Academy of Military Medical...UnknownSmall Colon Polyps | Linked Color Imagimg | Diminutive Colon PolypsChina
-
Massachusetts General HospitalNational Institutes of Health (NIH)Not yet recruitingColonoscopy | Colon Polyps
-
M.D. Anderson Cancer CenterRecruitingColon PolypsUnited States